Further, we found that RBM3 upregulated m6A methylation on CTNNB1 in a METTL3-dependent manner, resulting in decreased stability of CTNNB1 mRNA, thus affecting the adaptive survival of prostate cancer in the bone microenvironment [133]. The gene discussed is RBM3; the disease is prostate carcinoma.